{
    "clinical_study": {
        "@rank": "1518", 
        "arm_group": {
            "arm_group_label": "Cancer or no prior history of cancer", 
            "description": "Confirmed patients with breast, prostate, or colorectal cancer (OR) subjects with no prior history of cancer"
        }, 
        "brief_summary": {
            "textblock": "Objective: To test the sensitivity of a proprietary novel filtration device designed to\n      capture and concentrate circulating tumor cells (CTCs)."
        }, 
        "brief_title": "Collection of Blood Specimens for Circulating Tumor Cell Analysis", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Breast Cancer", 
            "Prostate Cancer", 
            "Colorectal Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Breast Neoplasms", 
                "Colorectal Neoplasms", 
                "Neoplastic Cells, Circulating", 
                "Prostatic Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age > 18 years of age\n\n          -  Written informed consent obtained\n\n          -  Confirmed diagnosis of stage 2-4 breast, prostate, or colorectal cancer, (OR) no\n             prior history of cancer\n\n          -  Stage 2-4 treatment naive, metastatic, secondary, and recurrent cancer patients\n\n          -  Able to undergo blood collection prior to initiation of chemotherapy treatment, (OR)\n             able to provide blood sample if subject is a non-cancer control subject\n\n        Exclusion Criteria:\n\n          -  Patients unable to understand the research protocol and/or provide informed consent.\n\n          -  Patients with known immunodeficiency, or pregnancy."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Confirmed patients with stage II-IV breast, prostate, or colorectal cancer, (Or) subjects\n        with no prior history of cancer."
            }
        }, 
        "enrollment": {
            "#text": "55", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01943500", 
            "org_study_id": "T30-0001"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Breast cancer", 
            "Prostate cancer", 
            "Colorectal cancer", 
            "Circulating tumor cell (CTC)"
        ], 
        "lastchanged_date": "September 21, 2013", 
        "location": {
            "contact": {
                "email": "psanz@chomed.com", 
                "last_name": "Pedro M Sanz-Altamira, MD, PhD", 
                "phone": "978-946-8230"
            }, 
            "facility": {
                "address": {
                    "city": "Lawrence", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "01841-2310"
                }, 
                "name": "Commonwealth Hematology-Oncology, P.C."
            }, 
            "investigator": {
                "last_name": "Pedro M Sanz-Altamira, MD, phD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Collection of Blood Specimens for Circulating Tumor Cell Analysis", 
        "overall_official": {
            "affiliation": "Commonwealth Hematology-Oncology, P.C.", 
            "last_name": "Pedro M Sanz-Altamira, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Blood samples will be collected from study subjects and analyzed for the number of circulating tumor cells (CTCs) within 96 hours of blood collection.", 
            "measure": "The number of circulating tumor cells (CTCs) per milliliter of whole blood. Reported unit of measure will be the number of CTCs/milliliter.", 
            "safety_issue": "No", 
            "time_frame": "Analysis will be performed within 96 hours following blood sample collection"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01943500"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Viatar LLC", 
        "sponsors": {
            "collaborator": {
                "agency": "Commonwealth Hematology-Oncology, P.C.", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Viatar LLC", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "September 2013"
    }
}